EDUCATING LEADERS IN PHARMACY AND PHARMACEUTICAL SCIENCES SINCE 1886
Qing Ma, PharmD, PhD, chosen to serve in NIH Study Section on HIV Comorbidities and Clinical Studies
By Kara Sweet
Published May 20, 2021
Qing Ma, PharmD, PhD, associate professor, pharmacy practice, has been selected to serve as a member of the National Institutes of Health HIV Comorbidities and Clinical Studies Study Section, Center for Scientific Review.
Ma is the only member on the panel from a department of pharmacy practice. His term will begin on July 1, 2021 and run for four years.
Members are selected on the basis of their demonstrated competence and achievement in their scientific discipline as evidenced by the quality of research accomplishments, publications in scientific journals, and other significant scientific activities, achievements and honors.
Ma has developed a broad research program that has expanded and evolved into investigating pharmacokinetics and pharmacodynamics of antiretroviral therapy on the central nervous system, pharmacogenomics, drug-drug interactions, and polypharmacy in relation to neurocognitive function in the elderly living with HIV. His research projects involve a multidisciplinary team that encompasses pharmacy, clinical pharmacology, neurology, psychology, substance use disorders and biomarker disciplines.
For over 130 years, the University at Buffalo School of Pharmacy and Pharmaceutical Sciences has continually been a leader in the education of pharmacists and pharmaceutical scientists, renowned for innovation in clinical practice and research. The school is accredited by the American Council of Pharmaceutical Education and is the No. 1 ranked school of pharmacy in New York State and No. 14 in the United States by U.S. News & World Report.
For more information about the UB School of Pharmacy and Pharmaceutical Sciences visit pharmacy.buffalo.edu.